| Phrase | Consultant | Town | Special Interests |
| Cardiovascular clinical genetics | *Consultant(s)* | *Towns* | Cardiovascular clinical genetics |
Clinical biochemistry | *Consultant(s)* | *Towns* | Clinical biochemistry, metabolic medicine, osteoporosis, metabolic bone disease, menopause, appraisal and revalidation | Clinical Genetics | *Consultant(s)* | *Towns* | Familial cancer | Clinical Genetics | *Consultant(s)* | *Towns* | Endocrine genetics, cancer genetics | Clinical Genetics | *Consultant(s)* | *Towns* | The genetics of renal disease | clinical negligence | *Consultant(s)* | *Towns* | PTSD - post-traumatic stress disorder, depression, clinical negligence, somatisation, psychiatric intensive care, eating disorders | clinical negligence | *Consultant(s)* | *Towns* | Personal injury, intensive care, emergency medicine, clinical negligence | Clinical Neurophysiology | *Consultant(s)* | *Towns* | Paediatric neuromuscular disease, epilepsy | Clinical Neurophysiology | *Consultant(s)* | *Towns* | Nerve conduction, EMG - electromyography, carpal tunnel syndrome, peripheral neuropathies, electromyographic guided botulinum toxin injections | Clinical Neurophysiology | *Consultant(s)* | *Towns* | Neuromuscular diseases, epilepsy, nerve conduction studies | Clinical Neurophysiology | *Consultant(s)* | *Towns* | Nerve conduction studies, electroencephalography, EMG - electromyography | Clinical Neuropsychology | *Consultant(s)* | *Towns* | Neuropsychology, epilepsy, neuropsychological functioning, head injury assessment | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology, breast cancer, lung cancer, sarcoma, teenage and young adult oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, head and neck cancer, ocular malignancy, urological tumours, soft tissue tumours | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, lung cancer, prostate brachytherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, central nervous system cancers, upper gastrointestinal cancers | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, central nervous system tumours | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal cancer including oesophageal, gastric, hepatopancreatobiliary and colorectal cancers, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, contact radiotherapy for early rectal cancer, gastrointestinal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper gastrointestinal cancer, breast cancer, paediatric radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, colorectal cancer, lung cancer | Clinical Pharmacology | *Consultant(s)* | *Towns* | Therapeutics, general internal medicine | clinical pharmacology | *Consultant(s)* | *Towns* | HIV, clinical pharmacology | clinical pharmacology | *Consultant(s)* | *Towns* | Adverse drug reactions, pharmacogenetics, clinical pharmacology | clinical pharmacology and therapeutics | *Consultant(s)* | *Towns* | General internal medicine, clinical pharmacology and therapeutics | clinical pharmacology of pain | *Consultant(s)* | *Towns* | Neuropathic pain, clinical pharmacology of pain, botox for peripheral neuropathic pain, high dose capsaicin patches, spinal cord and peripheral nerve stimulation for peripheral neuropathic pain, repetitive transcranial magnetic stimulation, opioid management, fibromyalgia | clinical trial design and reporting | *Consultant(s)* | *Towns* | Interventional cardiology, stenting, angioplasty, clinical trial design and reporting, alcohol ablation in hypertrophic obstructive cardiomyopathy, transcatheter aortic valve implantation - TAVI | core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery | Early phase clinical trials | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery | early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, early phase clinical trials, immunotherapy |
